Prometheus Biosciences to Present at 2021 RBC Capital Markets Global Healthcare Conference
May 14, 2021 16:01 ET
|
Prometheus Biosciences
SAN DIEGO, May 14, 2021 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery,...
Prometheus Biosciences Reports First Quarter 2021 Financial Results and Provides a Corporate Update
May 13, 2021 16:01 ET
|
Prometheus Biosciences
-PRA023, an anti-TL1A mAb, on track to initiate Phase 2 study for Ulcerative Colitis and Phase 2a study for Crohn’s Disease in 3Q 2021- -Launched Prometheus Enroll360™, a global patient recruitment...